메뉴 건너뛰기




Volumn 30, Issue 24, 2009, Pages 3015-3026

Effects of low-dose oral enoximone administration on mortality, morbidity, and exercise capacity in patients with advanced heart failure: The randomized, double-blind, placebo-controlled, parallel group ESSENTIAL trials

(21)  Metra, Marco a   Eichhorn, Eric b   Abraham, William T c   Linseman, Jennifer d   Böhm, Michael e   Corbalan, Ramon f   Demets, David g   De Marco, Teresa h   Elkayam, Uri i   Gerber, Michael d   Komajda, Michel j   Liu, Peter k   Mareev, Vyacheslev l   Perrone, Sergio V m   Poole Wilson, Philip n   Roecker, Ellen g   Stewart, Jennifer d   Swedberg, Karl o   Tendera, Michal p   Wiens, Brian d   more..


Author keywords

Advanced heart failure; Enoximone; Inotropic agents

Indexed keywords

ENOXIMONE; PLACEBO;

EID: 70449531838     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehp338     Document Type: Article
Times cited : (107)

References (28)
  • 3
    • 0032912752 scopus 로고    scopus 로고
    • Long-term survival in severe heart failure in patients treated with enalapril Ten year follow-up of CONSENSUS i
    • Swedberg K, Kjekshus J, Snapinn S. Long-term survival in severe heart failure in patients treated with enalapril. Ten year follow-up of CONSENSUS I. Eur Heart J 1999;20:136-139.
    • (1999) Eur Heart J , vol.20 , pp. 136-139
    • Swedberg, K.1    Kjekshus, J.2    Snapinn, S.3
  • 4
    • 0037716744 scopus 로고    scopus 로고
    • Effect of enalapril on 12-year survival and life expectancy in patients with left ventricular systolic dysfunction: A follow-up study
    • Jong P, Yusuf S, Rousseau MF, Ahn SA, Bangdiwala SI. Effect of enalapril on 12-year survival and life expectancy in patients with left ventricular systolic dysfunction: a follow-up study. Lancet 2003;361:1843-1848.
    • (2003) Lancet , vol.361 , pp. 1843-1848
    • Jong, P.1    Yusuf, S.2    Rousseau, M.F.3    Ahn, S.A.4    Bangdiwala, S.I.5
  • 5
    • 19944413618 scopus 로고    scopus 로고
    • Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator
    • Multicenter Automatic Defibrillator Implantation Trial-II (MADIT-II) Research Group
    • Moss AJ, Greenberg H, Case RB, Zareba W, Hall WJ, Brown MW, Daubert JP, McNitt S, Andrews ML, Elkin AD, Multicenter Automatic Defibrillator Implantation Trial-II (MADIT-II) Research Group. Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator. Circulation 2004;110:3760-3765.
    • (2004) Circulation , vol.110 , pp. 3760-3765
    • Moss, A.J.1    Greenberg, H.2    Case, R.B.3    Zareba, W.4    Hall, W.J.5    Brown, M.W.6    Daubert, J.P.7    McNitt, S.8    Andrews, M.L.9    Elkin, A.D.10
  • 7
    • 33645058195 scopus 로고    scopus 로고
    • Are hemodynamic goals viable in tailoring heart failure therapy? Hemodynamic goals are relevant
    • Stevenson LW. Are hemodynamic goals viable in tailoring heart failure therapy? Hemodynamic goals are relevant. Circulation 2006;113:1020-1027.
    • (2006) Circulation , vol.113 , pp. 1020-1027
    • Stevenson, L.W.1
  • 8
    • 0037901406 scopus 로고    scopus 로고
    • Clinical assessment identifies hemodynamic profiles that predict outcomes in patients admitted with heart failure
    • Nohria A, Tsang SW, Fang JC, Lewis EF, Jarcho JA, Mudge GH, Stevenson LW. Clinical assessment identifies hemodynamic profiles that predict outcomes in patients admitted with heart failure. J Am Coll Cardiol 2003;41:1797-1804.
    • (2003) J Am Coll Cardiol , vol.41 , pp. 1797-1804
    • Nohria, A.1    Tsang, S.W.2    Fang, J.C.3    Lewis, E.F.4    Jarcho, J.A.5    Mudge, G.H.6    Stevenson, L.W.7
  • 9
    • 0038313209 scopus 로고    scopus 로고
    • Development of circulatory-renal limitations to angiotensin-converting enzyme inhibitors identifies patients with severe heart failure and early mortality
    • Kittleson M, Hurwitz S, Shah MR, Nohria A, Lewis E, Givertz M, Fang J, Jarcho J, Mudge G, Stevenson LW. Development of circulatory-renal limitations to angiotensin-converting enzyme inhibitors identifies patients with severe heart failure and early mortality. J Am Coll Cardiol 2003;41:2029-2035.
    • (2003) J Am Coll Cardiol , vol.41 , pp. 2029-2035
    • Kittleson, M.1    Hurwitz, S.2    Shah, M.R.3    Nohria, A.4    Lewis, E.5    Givertz, M.6    Fang, J.7    Jarcho, J.8    Mudge, G.9    Stevenson, L.W.10
  • 11
    • 0033558697 scopus 로고    scopus 로고
    • Use of cardiopulmonary exercise testing with hemodynamic monitoring in the prognostic assessment of ambulatory patients with chronic heart failure
    • Metra M, Faggiano P, D'Aloia A, Nodari S, Gualeni A, Raccagni D, Dei Cas L. Use of cardiopulmonary exercise testing with hemodynamic monitoring in the prognostic assessment of ambulatory patients with chronic heart failure. J Am Coll Cardiol 1999;33:943-950.
    • (1999) J Am Coll Cardiol , vol.33 , pp. 943-950
    • Metra, M.1    Faggiano, P.2    D'Aloia, A.3    Nodari, S.4    Gualeni, A.5    Raccagni, D.6    Dei Cas, L.7
  • 12
    • 0035376795 scopus 로고    scopus 로고
    • Inotropes and beta-blockers: Is there a need for new guidelines?
    • Bristow MR, Shakar SF, Linseman JV, Lowes BD. Inotropes and beta-blockers: is there a need for new guidelines? J Card Fail 2001;7(Suppl. 1):8-12.
    • (2001) J Card Fail , vol.7 , Issue.SUPPL. 1 , pp. 8-12
    • Bristow, M.R.1    Shakar, S.F.2    Linseman, J.V.3    Lowes, B.D.4
  • 13
    • 20344401818 scopus 로고    scopus 로고
    • Mechanisms and models in heart failure: The biomechanical model and beyond
    • Mann DL, Bristow MR. Mechanisms and models in heart failure: the biomechanical model and beyond. Circulation 2005;111:2837-2849.
    • (2005) Circulation , vol.111 , pp. 2837-2849
    • Mann, D.L.1    Bristow, M.R.2
  • 17
    • 0025071304 scopus 로고
    • Multicenter trial of oral enoximone in patients with moderate to moderately severe congestive heart failure. Lack of benefit compared with placebo. Enoximone Multicenter Trial Group
    • Uretsky BF, Jessup M, Konstam MA, Dec GW, Leier CV, Benotti J, Murali S, Herrmann HC, Sandberg JA. Multicenter trial of oral enoximone in patients with moderate to moderately severe congestive heart failure. Lack of benefit compared with placebo. Enoximone Multicenter Trial Group. Circulation 1990;82:774-780.
    • (1990) Circulation , vol.82 , pp. 774-780
    • Uretsky, B.F.1    Jessup, M.2    Konstam, M.A.3    Dec, G.W.4    Leier, C.V.5    Benotti, J.6    Murali, S.7    Herrmann, H.C.8    Sandberg, J.A.9
  • 18
    • 0027966175 scopus 로고
    • Treatment of severe heart failure: Quantity or quality of life? A trial of enoximone. Enoximone Investigators
    • Cowley AJ, Skene AM. Treatment of severe heart failure: quantity or quality of life? A trial of enoximone. Enoximone Investigators. Br Heart J 1994;72:226-230.
    • (1994) Br Heart J , vol.72 , pp. 226-230
    • Cowley, A.J.1    Skene, A.M.2
  • 19
    • 0037010006 scopus 로고    scopus 로고
    • Beta-blocker therapy influences the hemodynamic response to inotropic agents in patients with heart failure: A randomized comparison of dobutamine and enoximone before and after chronic treatment with metoprolol or carvedilol
    • Metra M, Nodari S, D'Aloia A, Muneretto C, Robertson AD, Bristow MR, Dei Cas L. Beta-blocker therapy influences the hemodynamic response to inotropic agents in patients with heart failure: a randomized comparison of dobutamine and enoximone before and after chronic treatment with metoprolol or carvedilol. J Am Coll Cardiol 2002;40:1248-1258.
    • (2002) J Am Coll Cardiol , vol.40 , pp. 1248-1258
    • Metra, M.1    Nodari, S.2    D'Aloia, A.3    Muneretto, C.4    Robertson, A.D.5    Bristow, M.R.6    Dei Cas, L.7
  • 20
    • 0035664504 scopus 로고    scopus 로고
    • Milrinone versus dobutamine in heart failure subjects treated chronically with carvedilol
    • Lowes BD, Tsvetkova T, Eichhorn EJ, Gilbert EM, Bristow MR. Milrinone versus dobutamine in heart failure subjects treated chronically with carvedilol. Int J Cardiol 2001;81:141-149.
    • (2001) Int J Cardiol , vol.81 , pp. 141-149
    • Lowes, B.D.1    Tsvetkova, T.2    Eichhorn, E.J.3    Gilbert, E.M.4    Bristow, M.R.5
  • 22
    • 0342437444 scopus 로고    scopus 로고
    • Improvement of post-receptor events by metoprolol treatment in patients with chronic heart failure
    • Böhm M, Deutsch HJ, Hartmann D, Rosee KL, Stäblein A. Improvement of post-receptor events by metoprolol treatment in patients with chronic heart failure. J Am Coll Cardiol 1997;30:992-996.
    • (1997) J Am Coll Cardiol , vol.30 , pp. 992-996
    • Böhm, M.1    Deutsch, H.J.2    Hartmann, D.3    Rosee, K.L.4    Stäblein, A.5
  • 23
    • 0025732883 scopus 로고
    • Oral enoximone therapy in chronic heart failure: A placebo-controlled randomized trial. the Western Enoximone Study Group
    • Narahara KA. Oral enoximone therapy in chronic heart failure: a placebo-controlled randomized trial. The Western Enoximone Study Group. Am Heart J 1991;121:1471-1479.
    • (1991) Am Heart J , vol.121 , pp. 1471-1479
    • Narahara, K.A.1
  • 26
    • 0031694050 scopus 로고    scopus 로고
    • Superiority of 'triple' drug therapy in heart failure: Insights from the PROVED and RADIANCE trials. Prospective Randomized Study of Ventricular Function and Efficacy of Digoxin. Randomized Assessment of Digoxin and Inhibitors of Angiotensin-Converting Enzyme
    • Young JB, Gheorghiade M, Uretsky BF, Patterson JH, Adams KF Jr. Superiority of 'triple' drug therapy in heart failure: insights from the PROVED and RADIANCE trials. Prospective Randomized Study of Ventricular Function and Efficacy of Digoxin. Randomized Assessment of Digoxin and Inhibitors of Angiotensin-Converting Enzyme. J Am Coll Cardiol 1998;32:686-692.
    • (1998) J Am Coll Cardiol , vol.32 , pp. 686-692
    • Young, J.B.1    Gheorghiade, M.2    Uretsky, B.F.3    Patterson, J.H.4    Adams KF, Jr.5
  • 28
    • 17444416672 scopus 로고    scopus 로고
    • Six minute corridor walk test as an outcome measure for the assessment of treatment in randomized, blinded intervention trials of chronic heart failure: A systematic review
    • Olsson LG, Swedberg K, Clark AL, Witte KK, Cleland JG. Six minute corridor walk test as an outcome measure for the assessment of treatment in randomized, blinded intervention trials of chronic heart failure: a systematic review. Eur Heart J 2005;26:778-793.
    • (2005) Eur Heart J , vol.26 , pp. 778-793
    • Olsson, L.G.1    Swedberg, K.2    Clark, A.L.3    Witte, K.K.4    Cleland, J.G.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.